Appetite Hormones in Binge Eating Disorder
Binge Eating Disorder
About this trial
This is an interventional treatment trial for Binge Eating Disorder focused on measuring Appetite Hormones, Binge Eating Disorder, Obesity, Cortisol, Stress
Eligibility Criteria
Inclusion Criteria:
- BMI of 20-25 or 30-50
- stable weight(± 4%) for at least 3 mo
- premenopausal and have regular menstrual cycles (28 d ± 5), not be pregnant or lactating, and not be within 1 y of childbirth
- must like pizza and be willing to consume it during the ad libitum meal
Exclusion Criteria:
- significant medical or psychiatric conditions
- current and past 3-mo use of certain prescribed medications, especially those that could affect body weight, such as antidepressants and stimulants as well as smoking, or excess alcohol (> 3 drinks/d)
- vigorously exercise for more than 6 h/wk
- left-handed, with known claustrophobia for a scanner enclosure, or have metal implants, non-removable metallic dental retainers, pacemakers, or permanent eyeliner or large tattoos that contain metallic pigment
Sites / Locations
- St. Luke's Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Obese subjects with BED
Obese without BED
Normal-weight without BED
Subjects who meet the BMI requirement for obesity (>30 kg/m^2) and the DSM requirements for binge eating disorder based on responses to validated questionnaires. Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.
Subjects who meet the BMI requirement for obesity (>30 kg/m^2) but who do not meet the DSM requirements for binge eating disorder based on responses to validated questionnaires. Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.
Subjects with BMI 20-25 kg/m^2 who do not meet the DSM requirements for binge eating disorder based on responses to validated questionnaires. Subjects will undergo the postprandial responses, cold pressor test and ad libitum test meal.